Physical Activity and Its Relationship with Patient Characteristics, Symptoms, Quality of Life, and Depression in Irritable Bowel Syndrome-A Cross-Sectional Study
Abstract
Aim: To investigate physical activity and its relationship with symptoms, quality of life (QoL), and depression in patients with Irritable Bowel Syndrome (IBS).
Material and Methods: Eighty IBS patients (42 female, 38 male) were included. Subtypes of IBS, patient characteristics, symptoms (Gastrointestinal Symptom Rating Scale), QoL [Irritable Bowel Syndrome Quality of Life Scale (IBS-QoL)], depression (Beck Depression Scale), and physical activity (International Physical Activity Questionnaire (IPAQ)) were assessed. Abdominal pain severity was evaluated with visual analogue scale (VAS).
Results: The demographic and clinical characteristics of the IBS subtypes (IBS-constipation [IBS-C]=36, IBS-diarrhea [IBS-D]=20, IBS-mixed [IBS-M]=24) were similar (p>0.05). The mean of abdominal pain VAS was 5.81±1.92. Most of the participants were minimally active (n=44, 55%) and inactive (n=29, 36.3%). IBS-M had worse interpersonal relationships (p=0.006) and was more depressed (p=0.020) than the IBS-C. Patient characteristics did not show a significant correlation with physical activity (p>0.05). Physical activity had a moderate correlation with symptoms (r=-0.508, p<0.001) and QoL (r=0.467, p<0.001), and had a weak correlation with depression (r=-0.284, p=0.001) in all participants. Physical activity had a moderate negative correlation with symptom severity (r=-0.421-(-0.596); p=0.011, p=0.006, p=0.009) and a positive moderate correlation with QoL (r=0.415-0.568; p=0.006, p=0.009, p=0.044), but no significant correlation with depression (p=0.106-0.357) in IBS-C, IBS-D, and IBS-M subtypes, respectively.
Conclusion: IBS patients had low levels of physical activity. There were negative correlations between symptom severity and depression and physical activity levels, while QoL demonstrated a positive correlation in all participants.
Keywords
Supporting Institution
Ethical Statement
Thanks
References
- Camilleri M. Management of the irritable bowel syndrome. Gastroenterology. 2001;120(3):652-68. doi:10.1053/gast.2001.21944.
- Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17-44. doi:10.14309/ajg.0000000000001036.
- Ünsal NE, Akbulut G, Gülşen M. Effects of fiber or probiotic yogurt supplementation on intestinal barrier integrity in constipation-predominant irritable bowel syndrome. Gulhane Med J. 2024;66(4):176-84. doi:10.4274/gulhane.galenos.2024.05900.
- Defrees DN, Bailey J. Irritable bowel syndrome: epidemiology, pathophysiology, diagnosis, and treatment. Prim Care. 2017;44(4):655-71. doi:10.1016/j.pop.2017.07.009.
- Tetali B, Suresh S. Management of irritable bowel syndrome: a narrative review. Transl Gastroenterol Hepatol. 2024;21;9:26. doi:10.21037/tgh-23-96.
- Fukui A, Naito Y, Kamada K, Takagi, T. The role of microbiota in the pathophysiology of irritable bowel syndrome. In: Kamiya T, Fukudo S, editors. Irritable bowel syndrome [Internet]. Singapore: Springer; 2024. p. 43-50. doi:10.1007/978-981-97-8410-3_5.
- Cho HS, Park JM, Lim CH, Cho YK, Lee IS, Kim SW, et al. Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver. 2011;5(1):29. doi:10.5009/gnl.2011.5.1.29.
- Mönnikes H. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol. 2011;45 Suppl:S98-101. doi:10.1097/MCG.0b013e31821fbf44.
Details
Primary Language
English
Subjects
Clinical Sciences (Other)
Journal Section
Research Article
Publication Date
May 24, 2026
Submission Date
April 26, 2025
Acceptance Date
April 24, 2026
Published in Issue
Year 2026 Volume: 16 Number: 2